You searched for "regeneration"
Retina UK Annual Conference 2025
The Retina UK Conference is an excellent opportunity to find out the latest news from Retina UK, hear from expert speakers, meet other members of our community and to make new connections. The line-up for their 50th anniversary year conference...
PI drops and respiratory change during surgery
Five percent povidone-iodine (PI) topical application to the eye has been observed to cause apnoea under general anaesthetic (GAS). The authors designed a randomised single-blinded controlled trial to evaluate changes in respiration caused by PI eye drops. They recruited 100...A missed intraocular telescope – an opportunity to re-focus the evidence
Intraocular telescopes allow magnification of the image so that it would be projected into a larger area of the macula, this makes the central defect caused by dry age-related macular degeneration (AMD) smaller. The most common approach is a Galilean...AOP launches research into key reforms proposed for primary eye care services in Wales
The Welsh Government put forward proposals for major reforms of primary eye care servicesAOP update on new GOC e-service for statutory notices
The GOC intends to introduce email communication for statutory notices with consent.American Glaucoma Society (AGS) Annual Meeting 2025
Important Dates September 5, 2024: Abstract Submission and Surgical Video Submission Opens October 10, 2024 : Abstract Submission Site ClosesOctober 17, 2024: Registration and Housing open to AGS Members OnlyOctober 17, 2024: Surgical Video Submission ClosesNovember 15, 2024: Registration and...Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics
Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...Advances and developments in medical retina
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...
